Follow-up of the intervention and adverse events
re-infections
ADVERSE EVENTS, REINFECTION, BLIND
This was a remote and uncontrolled intervention. However, a follow-up call was made six weeks after the start of the intervention, that is, halfway through the process.Prior to the start of the intervention, the researchers established the following adverse events: reinfection with COVID-19, use of emergency medical services, hospitalization or surgical interventions, or any other circumstance that could disrupt the intervention. In addition, all participants were provided with a telephone number to report any adverse events occurring throughout the study, either by phone call or text message. Participants were also asked about the occurrence of adverse events during the follow-up call and the second assessment. During the intervention, it was not necessary to assess adverse events other than those mentioned above. Two independent researchers, blind to the group assignment, assessed all reported adverse events (re-infections). Any disagreements were resolved through the participation of a third researcher.